Paul Grevitt

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Clonal LIMD1 loss drives PD-L1 immune evasion via ARIH1-dependent ubiquitination in lung cancer
  Kunal Shah, Paul T. Kennedy, James R. Black

  +13 more

  • Piotr Pawlik
  • Kevin Litchfield
  • Krupa Thakkar
  • Maria F. Contreras G.
  • Kirsten Brooksbank
  • +8 more
  Life Science Alliance 2026 DOI: 10.26508/lsa.202603812
  +Save
• The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting
  Alex F. F. Crozier, Kunal Shah, Paul Grevitt +12 more
  Science Advances 2026 DOI: 10.1126/sciadv.aed6875
  +Save
• C-terminal tagging impairs AGO2 function
  RNA Biology 2025 DOI: 10.1080/15476286.2025.2534028
  +Save
• An AGO2 adaptor expands the functional and evolutionary reach of microRNA targeting
  2025 DOI: 10.1101/2025.10.07.680889
  +Save
• Coenzyme A homeostasis regulates hypoxic signalling via UBFD1 in triple-negative breast cancer
  2025 DOI: 10.1101/2025.06.18.660436
  +Save
• LIMD1 Loss Confers a GPX4-Dependent Cell State in Lung Cancer
  Akash Saha, Paul Grevitt, Jair Marques Junior

  +7 more

  • Alex von Kriegsheim
  • Kunal Shah
  • Zhen Gao
  • Brent R. Stockwell
  • Andrew J. Finch
  • +2 more
  2025 DOI: 10.1101/2025.06.06.658274
  +Save
• LIMD1 Loss as an Early Driver of PD-L1 Upregulation and Immune Evasion in Lung Cancer
  Kunal M. Shah, Paul T. Kennedy, James R. Black +12 more
  2025 DOI: 10.1101/2025.02.06.636805
  +Save
• C-terminal tagging impairs AGO2 function
  2023 DOI: 10.1101/2023.11.20.567203
  +Save
• The glucose transporter 2 regulates CD8+ T cell function via environment sensing
  Nature Metabolism 2023 DOI: 10.1038/s42255-023-00913-9
  +Save
• Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes
  Kathryn M Davidson, Paul Grevitt, Maria F. Contreras G. +11 more
  Cell Death & Disease 2021 DOI: 10.1038/s41419-021-04355-7
  +Save
• Targeted therapy forLIMD1-deficient non-small cell lung cancer subtypes
  2021 DOI: 10.1101/2021.02.01.429178
  +Save
• miR-132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity.
  EMBO reports 2019 DOI: 10.15252/embr.201846620
  +Save
• A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia
  Daniel E. Foxler, Katherine S. Bridge, John Gordon Foster +24 more
  EMBO Molecular Medicine 2018 DOI: 10.15252/emmm.201708304
  +Save